A comparative clinical to evaluate the efficacy of prabhakara vati with sarpagandha vati in shonita dusti with special reference to essential hypertension
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Headache reduced
研究概览
简要总结
The samanya chikitsa of Shonita dusti is Raktapittahara kriya, Virechana, Upavasaa and Rakta sravana . In that Raktapittahara kriya plays vital role in planning the treatment,which mainly aimed as Vyadhipratyanika and Samprapti vighatana Chikitsa.
On classical literature analysis the main siddhanta of chikitsa is Samprapti vighatana of the disease. Prabhakar vati is one such drug which is mentioned in Hrudrogadhikar of Bhaishajya Ratnavali. Its constituents helps to do Samprapti vighatana of Shonita dusti and also helps to prevent further complications caused by Essential hypertension, as it contains swarnamakshika bhasma, Loha bhasma, Abhraka bhasma, Vamshalochana, Shilajatu and Arjuna kwath as bhavana dravya
. It is having Madhura, Tikta rasa, Sheeta veerya and overall karmukata is Pitta Shamana with Tridosha hara properties. Thus does the Shamana of Vyadhis caused by Shonita dusti . Hence Prabhakra vati is choosen for the current study.Sarpagandha vati is explained under Brama-Anidra-Unmad adhikar of Siddhayoga sangraha and it contains Sarpagandha, Jatamansi, Parasika Yavani, Pippalimoola, Bhanga.Sarpagandha vati is having predominantly having Tikta rasa and act as Raktashodhaka. It is nidrajanak and a nutrient for brain, which can be used to relieve anxiety, stress and mental fatigue
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 30.00 Year(s) 至 60.00 Year(s)(—)
- 性别
- All
入选标准
- •Patients presenting with samanya lakshana of Shonita dusti.
排除标准
- •Patients with history of cerebrovascular accident, chronic kidney disease.
- •diabetic mellitus other systemic,Metabolic disorders.
- •Patients having secondary hypertension.
- •Patients with history of Disorders related with haemopoietic system like Leukemia Hemophilia Unconscious, Coma patient, and Patients who are suffering with Gastro-intestinal bleeding disorders.
结局指标
主要结局
Headache reduced
时间窗: After 14 days
次要结局
- Improved in generalised weakness and daily activities(After 21 days of treatment)
研究者
Jyoti Ashok Belavi
Shri Shivayoogeeshwar Rural Ayurvedic College Hospital Inchal
